至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2.

Oncol Lett. 2016; 
ZhaoXiaojuan,ZhouYun,ChenY U,Yu
Products/Services Used Details Operation
Gene Synthesis Experiments were repeated three times. The primer sequences were as follows (Genscript, Nanjing, China): FGFR2 forward, 5′-TGACATTAACCGTGTTCCTGAG-3′ and reverse, 5′-TGGCGAGTCCAAAGTCTGCTAT-3′; β-actin forward, 5′-GACCTCTATGCCAACACAGT-3′ and reverse, 5′-AGTACTTGCGCTCAGGAGGA-3′. Get A Quote

摘要

MicroRNAs (miRs) have been reported to be key regulators in numerous types of cancer. The aim of the present study was to investigate the role of miR-494 in ovarian cancer. Expression of miR-494 was analyzed in ovarian cancer tissues and cell lines by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). miR-494 mimic or negative control was transiently transfected into A2780 and SKOV3 cell lines. A cell counting kit-8 assay was performed to assess the effects of miR-494 on cell proliferation, and flow cytometry was used to evaluate the apoptotic rate. The target gene of miR-494 was detected by luciferase assay. Expression of fibroblast growth factor receptor 2 (FGFR2) was identified using R... More

关键词

apoptosis,fibroblast growth receptor 2,microRNA-494,ovarian cancer,prolifera